REQUEST A DEMO
Total
USD $0.00
Search more companies

i-Sens Inc. (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: i-Sens Inc. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

i-SENS, Inc is a healthcare company specializing in diabetes healthcare devices. The company supplies POCT devices, Immunoassay Analyzer, and CGMS, with an annual production capacity of 2.1 billion test strips. i-SENS exports to over 110 countries, including the USA, Japan, and Europe.

Headquarters
I-Sens Building, Banpo-Daero 28-Gil 43, Seocho-Gu
Seoul; Seoul; Postal Code: 139-845

Contact Details: Purchase the i-Sens Inc. report to view the information.

Website: http://www.i-sens.com

Basic Information
Total Employees:
Purchase the i-Sens Inc. report to view the information.
Outstanding Shares:
Purchase the i-Sens Inc. report to view the information.
Registered Capital:
Purchase the i-Sens Inc. report to view the information.
Financial Auditors:
Purchase the i-Sens Inc. report to view the information.
Incorporation Date:
May 04, 2000
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
16.76%
Purchase this report to view the information.
8.08%
Purchase this report to view the information.
1.01%
Subsidiaries
I-Sens Biosensors Malaysia Sdn Bhd
100%
I-Sens Chile Spa
100%
I-Sens Gmbh I G
100%
Company Performance
Financial values in the chart are available after i-Sens Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-4.48%
Total operating revenue
-4.25%
Operating profit (EBIT)
-64.07%
EBITDA
-41.11%
Net Profit (Loss) for the Period
-64.97%
Total assets
5.48%
Total equity
-0.28%
Operating Profit Margin (ROS)
-6.13%
Net Profit Margin
-5.44%
Return on Equity (ROE)
-3.59%
Debt to Equity Ratio
9.63%
Quick Ratio
-1.08%
Cash Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?